Medicare Enrolled

Dr. Sally Decastro-Tilsen, P.A.

Physician Assistant · Newport Beach, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
400 NEWPORT CENTER DR STE 701, Newport Beach, CA 92660
9497598001
In practice since 2008 (17 years)
NPI: 1023282019 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Decastro-Tilsen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Decastro-Tilsen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Decastro-Tilsen

Dr. Sally Decastro-Tilsen is a physician assistant in Newport Beach, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Decastro-Tilsen performed 33,408 Medicare services across 325 unique beneficiaries.

Between the years covered by Open Payments, Dr. Decastro-Tilsen received a total of $68,505 from 57 pharmaceutical and/or device companies across 1140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Decastro-Tilsen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 0% volume in CA $68,505 industry payments

Medicare Practice Summary

Medicare Utilization ↗
33,408
Medicare services
Top 0% in CA for physician assistant
325
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,965 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
33,000 $5 $10
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
165 $115 $250
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
162 $111 $1,000
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
81 $78 $160
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$68,505
Total received (2021-2024)
Avg $17,126/year across 4 years
Top 0% in CA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,140
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$46,614 (68.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,891 (32.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,160
2023
$17,359
2022
$18,191
2021
$21,795

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,070
UCB, Inc.
$1,217
Teva Pharmaceuticals USA, Inc.
$921
Neurocrine Biosciences, Inc.
$915
PFIZER INC.
$438
Axsome Therapeutics, Inc.
$370
Alexion Pharmaceuticals, Inc.
$368
Lundbeck LLC
$316
Eisai Inc.
$243
Abbott Laboratories
$223
Amneal Pharmaceuticals LLC
$206
Lilly USA, LLC
$184
Collegium Pharmaceutical, Inc.
$108
IDORSIA PHARMACEUTICALS US INC
$90
Azurity Pharmaceuticals, Inc.
$80
LivaNova USA, Inc.
$72
Tonix Medicines, Inc.
$69
SCILEX PHARMACEUTICALS INC.
$65
Janssen Pharmaceuticals, Inc
$55
Averitas Pharma Inc.
$30
Takeda Pharmaceuticals U.S.A., Inc.
$29
MITSUBISHI TANABE PHARMA AMERICA, INC.
$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
Amgen Inc.
$21
Valinor Pharma, LLC
$16
Top 3 companies account for 64.6% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$29,009
Allergan, Inc.
$13,180
AbbVie Inc.
$4,198
Teva Pharmaceuticals USA, Inc.
$3,448
UCB, Inc.
$2,774
Neurocrine Biosciences, Inc.
$1,874
Amgen Inc.
$1,414
Lilly USA, LLC
$1,397
Axsome Therapeutics, Inc.
$1,050
Alexion Pharmaceuticals, Inc.
$981
PFIZER INC.
$839
UPSHER-SMITH LABORATORIES LLC
$660
Biohaven Pharmaceutical Holding Company Ltd.
$653
LivaNova USA, Inc.
$607
Biohaven Pharmaceuticals, Inc.
$498
Amneal Pharmaceuticals LLC
$477
Collegium Pharmaceutical, Inc.
$475
Lundbeck LLC
$470
Janssen Pharmaceuticals, Inc
$403
IDORSIA PHARMACEUTICALS US INC
$403
SK Life Science, Inc.
$365
Eisai Inc.
$334
Alnylam Pharmaceuticals Inc.
$327
IMPEL PHARMACEUTICALS INC.
$287
Abbott Laboratories
$223
SCILEX PHARMACEUTICALS INC.
$159
JAZZ PHARMACEUTICALS INC.
$155
Kyowa Kirin, Inc.
$143
Azurity Pharmaceuticals, Inc.
$132
Almatica Pharma LLC
$131
MITSUBISHI TANABE PHARMA AMERICA, INC.
$119
Avanir Pharmaceuticals, Inc.
$119
Supernus Pharmaceuticals, Inc.
$107
Takeda Pharmaceuticals U.S.A., Inc.
$96
ARBOR PHARMACEUTICALS, INC.
$78
ACADIA Pharmaceuticals Inc
$75
Currax Pharmaceuticals LLC
$72
Tonix Medicines, Inc.
$69
Harmony Biosciences LLC
$65
Merck Sharp & Dohme Corporation
$64
Valinor Pharma, LLC
$58
Bausch Health US, LLC
$55
Biogen, Inc.
$55
Scilex Pharmaceuticals Inc.
$47
Merck Sharp & Dohme LLC
$38
Horizon Therapeutics plc
$36
Otsuka America Pharmaceutical, Inc.
$36
Genentech USA, Inc.
$30
Averitas Pharma Inc.
$30
Forte Bio-Pharma LLC
$29
Endo Pharmaceuticals Inc.
$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
RedHill Biopharma Inc.
$24
Alfasigma USA, Inc.
$23
EISAI INC.
$20
FORTE BIO-PHARMA LLC
$20
ARGENX US, INC.
$18
Top 3 companies account for 67.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · AMVUTTRA · AMYVID · APLENZIN · AUSTEDO · Aimovig · Austedo XR · Auvelity · BELSOMRA · BOTOX · Belbuca · Briviact · CAPLYTA · COMIRNATY · CONTRAVE · CREXONT · DUOPA · ELYXYB - celecoxib · EMGALITY · ETERNA · Fycompa · GRALISE · HORIZANT · Horizant · INGREZZA · KISUNLA · Leqembi · MOVANTIK · Movantik · NALOCET · NAPRELAN · NASCOBAL · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nucynta · Nuedexta · ONGENTYS · ONPATTRO · OXTELLAR XR · Ongentys · PAXLOVID · PROLATE · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · RYTARY · Rystiggo · SOLIRIS · SPRAVATO · SUNOSI · Soliris · Sunosi · TOSYMRA · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VNS - Symmetry · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VNS Therapy Symmetry Model 8103 Generator · VRAYLAR · VYEPTI · VYVGART · Vimpat · WAKIX · WELLBUTRIN · XCOPRI · XTAMPZA · ZEMBRACE SYMTOUCH · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in physician assistant and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for physician assistant in CA.

Looking for a physician assistant in Newport Beach?
Compare physician assistants in the Newport Beach area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
1,755
Per 100K population
55.5
County median income
$113,702
Nearest hospital
COLLEGE HOSPITAL COSTA MESA
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Decastro-Tilsen is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Decastro-Tilsen experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Decastro-Tilsen performed 33,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Decastro-Tilsen receive payments from pharmaceutical companies?
Yes. Dr. Decastro-Tilsen received a total of $68,505 from 57 companies across 1,140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Decastro-Tilsen's costs compare to other physician assistants in Newport Beach?
Dr. Decastro-Tilsen's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Decastro-Tilsen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →